Introduction: Ascites is a common major symptom in many digestive pathologies. It is the major complication of decompensated cirrhosis. Objective: to contribute to better management of ascites in Bangui. Patients and methods: This is a descriptive cross-sectional study lasting 30 months conducted in the Hepato-Gastroenterology department of the CHUASC in Bangui. We included in the study patients of both sexes hospitalized for ascites in whom the etiological diagnosis was known. Results: During the study period, 1210 patients were hospitalized, 204 of whom presented with ascites (16.85%), of whom 170 (14.9%) met our inclusion criteria. There were 100 men (58.8%) and 70 women (41.2%). The sex ratio was 1.42. The average age of the patients was 46 years old. The most common reasons for hospitalization were abdominal bloating in 155 cases (91.2%), OMI in 87 cases (51.2%), abdominal pain in 84 cases (49.4%). Weight loss was found in 134 cases (78.8%) and fever in 10 cases (5.9%). Ascites was of medium abundance in 89 cases (52.35%). The liver was cirrhotic on physical examination in 127 cases (74.7%). Conclusion: ascites is a frequent sign in hospitalization oftenassociated with abdominal bloating, edema of the lower limbs, abdominal pain, weight loss and fever. Men were the most affected, it mainly concerns young people. In both sexes. Introduction : L’ascite est un symptôme majeur fréquent dans beaucoup de pathologies digestives. Elle est la complication majeure de la cirrhose décompensée. Objectif : contribuer à une meilleure prise en charge de l’ascite à Bangui. Patients et méthodes : Il s’agit d’une étude transversale descriptive d’une durée de 30 mois menée dans le service d’Hépatogastroentérologie du CHU de l’Amitié Sino-Centrafricaine de Bangui. Elle a porté sur l’ascite chez des adultes des deux sexes dont le diagnostic étiologique était posé. Résultats : Durant la période d’étude, 1210 patients étaient hospitalisés dont 204 pour une ascite (16,85%), parmi lesquels 170 (14,9%) étaient inclus dans l’étude. On comptait 100 hommes (58,8%) et 70 femmes (41,2%). La sex-ratio était de 1,42. L’âge moyen des patients était de 46 ans. Les motifs d’hospitalisation les plus fréquents étaient le ballonnement abdominal dans 91,2% des cas suivi de l’oedème des membres inférieurs (OMI) (51,2%) et la douleur abdominale (49, 4%). L’amaigrissement était retrouvé dans 78,8% des cas. L’ascite était de moyenne abondance dans 52,35% des cas. Le foie était d’allure cirrhotique dans 74,7% des cas. Conclusion : l’ascite est un signe fréquent en hospitalisation. Le diagnostic étiologique pour la plupart hépatique compliquant souvent une cirrhose doit être recherché pour une meilleure prise en charge. Il concerne en majorité les hommes adultes jeunes.
Objective: To describe the epidemiological, clinical, biological and morphological aspects of primary liver cancer (PLC). Patients and Methods: We conducted a 38-month cross-sectional study in the Department of hepatogastroenterology and Internal Medicine "Amitié Sino-Centrafraine" University Hospital Center in Bangui. Included in the study were all patients with a diagnosis of PLC. The PLC's diagnostic arguments were the large tumor liver associated or not with the elevation of alpha-fetoprotein, the heteronodular liver hypervascularized on abdominal ultrasound. Data analysis was done using Epi Info 3.5.1 software. Results: We collected 115 cases of CPF among 2410 hospitalized patients (4.7%). There were 86 men and 29 women (sex ratio: 2.9). The average age was 50 years old. The main risk factors were alcohol consumption (72.2%) and chronic hepatitis B infection (67.4%). Frequent clinical signs were pain in the right hypochondrium and/or epigastric (93.86%), large tumor liver under examination (91.3%), weight loss (74.78%). The serum alpha-fetoprotein concentration was ≥ 400 ng/ml in 73% of the cases. The abdominal ultrasound found a heteronodular liver in all patients. The nodules were multiple hyperechoic in 66.1% of the cases. According to the Child-Pugh classification, the patients were classified as B (49.
Introduction: Cirrhosis is the final stage in the development of any chronic liver disease. The objective of our study was to determine the therapeutic route of patients with cirrhosis. Patients and Methods: This was a one-year cross-sectional study of consenting patients of both sexes with cirrhosis who were hospitalized for the first time. The study took place from October 1, 2013 to September 30, 2014. The diagnosis of cirrhosis was based on clinical, biological and morphological arguments. Results: In total, 1028 patients were hospitalized, including 202 for cirrhosis (19.6%). One hundred and four patients (10.1%) met our inclusion criteria. These were 70 men (67.3%) and 34 women (32.7%). The sex ratio was 2.05. The average age was 43.74 ± 13.74 years. In 68 cases (65.4%), cirrhosis was considered a supernatural disease and in 36 cases (34.6%) was a natural disease. At the first signs, 88 patients (84.6%) had consulted (traditional healer in 34 cases, pastor in 25 cases, marabout in 16 cases and general practitioner in 13 cases). The pastor prayed to 25 patients (24%). The traditional healer made the patients ingest herbal preparations (n = 18), associated or not with scarification (n = 4) and/or enema (n = 28). The marabout recited Quranic verses written on a board, then washed and ingested in 16 cases (15.4%). The general practitioner prescribed treatment to the 13 patients (12.5%). The various treatments received had led to hepatic encephalopathy (21 cases), digestive hemorrhage (15 cases), abdominal pain (3 cases), jaundice (3 cases), increased abdominal bloating (21 cases). The patients had consulted the specialist within an average of 74 ± 15.3 days. The average time to hospital was 21 days ± 13. Conclusion:
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.